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NASP is an H1 histone-binding protein that is cell
cycle-regulated and occurs in two major forms: tNASP,
found in gametes, embryonic cells, and transformed
cells; and sNASP, found in all rapidly dividing somatic
cells (Richardson, R. T., Batova, I. N., Widgren, E. E.,
Zheng, L. X., Whitfield, M., Marzluff, W. F., and O’Rand,
M. G. (2000) J. Biol. Chem. 275, 30378–30386). When full-
length tNASP fused to green fluorescent protein (GFP)
is transiently transfected into HeLa cells, it is efficiently
transported into the nucleus within 2 h after translation
in the cytoplasm, whereas the NASP nuclear localiza-
tion signal (NLS) deletion mutant (NASP-NLS-GFP) is
retained in the cytoplasm. In HeLa cells synchronized
by a double thymidine block and transiently transfected
to overexpress full-length tNASP or NASP-NLS, pro-
gression through the G1/S border is delayed. Cells tran-
siently transfected to overexpress the histone-binding
site (HBS) deletion mutant (NASP-HBS) or sNASP were
not delayed in progression through the G1/S border. By
using a DNA supercoiling assay, in vitro binding data
demonstrate that H1 histone-tNASP complexes can
transfer H1 histones to DNA, whereas NASP-HBS can-
not. Measurement of NASP mobility in the nucleus by
fluorescence recovery after photobleaching indicates
that NASP mobility is virtually identical to that re-
ported for H1 histones. These data suggest that
NASP-H1 complexes exist in the nucleus and that tNASP
can influence cell cycle progression through the G1/S
border through mediation of DNA-H1 histone binding.
Linker (H1) histones are involved in chromatin remodeling
events and frequently exchange between numerous linker-
binding sites on chromatin (2–4). Moreover, H1 histones have
been shown to influence G1/S phase progression (5) and in some
cases inhibit transcription initiation (6). Consequently, under-
standing the role of H1 histones is important for our under-
standing of both gene activation and chromatin organization
(7–9).
H1 histones not bound to DNA appear to be bound to the H1
histone-binding protein NASP, which has been characterized
previously in vivo and in vitro (1, 10, 11) as an acidic protein
containing functional histone-binding sites, a leucine zipper,
ATP/GTP-binding sites, and a functional nuclear localization
signal (11, 12). NASP occurs in two major forms as follows:
tNASP, found in gametes, embryonic cells, and transformed
cells; and sNASP, found in all dividing somatic cells (1). Mouse
sNASP (Mr 45,751) is identical to tNASP (Mr 83,934), except
that it lacks two internal regions of the protein (1, 10). Simi-
larly human tNASP and sNASP occur with identical deletions
to those found in the mouse (10, 13).
During the cell cycle, NASP mRNA expression in somatic
cells increases and decreases concurrently with histone mRNA
changes in expression (1). However, in rapidly dividing cells
protein levels of NASP remain fairly constant and only de-
crease to undetectable levels in non-dividing cells (1). Reports
that overexpression of H1 histones can influence progression
through the cell cycle (5) prompted us to investigate the effect
on progression through the cell cycle by overexpression of
NASP and to examine the relationship of NASP to H1 histones
in HeLa cells. In this report we demonstrate that 1) the over-
expression of tNASP does influence progression through the
cycle, 2) tNASP is bound to H1 histones in HeLa cells, 3) in
vitro complexes of tNASP-H1 will transfer H1 to DNA, and 4)
that NASP and H1 have virtually identical mobilities within
the nucleus.
EXPERIMENTAL PROCEDURES
All chemicals and reagents used in this study were molecular biology
grade. Restriction enzymes were purchased from Roche Diagnostics.
Purification of plasmid DNA and PCR products were carried out us-
ing QIAprep Miniprep and QIAquick PCR purification kits (Qiagen,
Valencia, CA), and sequencing was performed at the University of
North Carolina, Chapel Hill, automated sequencing facility. Affinity-
purified goat anti-green fluorescent protein antiserum was purchased
from Rockland (Gilbertsville, Pa); rabbit anti-histone H1 (FL-219) poly-
clonal antiserum was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA); and rabbit anti-NASP antiserum was prepared against
either N-terminal (nucleotides 96–1099) or C-terminal (nucleotides
1100–2414) recombinant proteins as described previously (1).
Construction of Expression Vectors—The entire coding sequence of
mouse tNASP (nucleotides 92–2405, GenBankTM accession number
AF034610) was amplified from mouse testis Quick-clone cDNA (Clon-
tech, Palo Alto, CA) using the Expand High Fidelity PCR System (Roche
Molecular Biochemicals) and cloned into a KpnI/BamHI site in the
pEGFP-N1 vector, which contains the sequence for expressing green
fluorescent protein (GFP1; Clontech, Palo Alto, CA). The nuclear local-
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ization signal (NLS) deletion mutant (NASP-NLS; nucleotides 92–
2192), which lacked the nuclear localization signal (nucleotides 2215–
2268), was PCR-amplified and cloned into the same pEGFP-N1 vector.
The entire coding region of mouse sNASP (nucleotides 254–1384, Gen-
BankTM accession number AF095722) (1) was also cloned into the
pEGFP-N1 vector. The histone-binding site deletion mutant (NASP-
HBS; nucleotides 527–1384), which lacked all histone-binding sites
(nucleotides 349–523) (11), was PCR-amplified and cloned into
pEGFP-N1.
For cell cycle studies, vectors lacking the GFP sequence were con-
structed from pEGFP-N1 by excising the GFP by sequential digest by
BamHI and NotI. Digested ends were repaired by Klenow enzyme and
ligated by T4 DNA ligase. All constructs were sequenced to verify the
correct reading frame.
For in vitro H1-binding studies, full-length tNASP and NASP-HBS
(amino acids 567–773) were cloned into His6 tag-pQE30 vectors. Re-
combinant proteins were expressed in BL21 (DE3) pLysS-competent
Escherichia coli cells and purified on nickel-nitrilotriacetic acid-agarose
columns (Qiagen, Valencia, CA).
Cell Studies—HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium-H plus 10% calf serum. Cells were removed from
plastic dishes by trypsinization in EDTA. Synchronized populations of
HeLa cells were obtained by double thymidine blocking as described
previously (1).
Indirect Immunofluorescence—HeLa cells were grown on chamber
slides with polystyrene wells (Falcon CultureSlide, BD Biosciences),
washed twice with cold (4 °C) PBS (phosphate-buffered saline, pH 7.0),
fixed with chilled (20 °C) methanol (20 min), washed twice with cold
PBS, and incubated in rabbit anti-NASP (N-terminal) antiserum or
preimmune serum (1:500) in PBS. Cells were incubated for 45 min,
washed in PBS (3, 5 min each), and incubated in fluorescein-conju-
gated, affinity-purified goat anti-rabbit IgG Fc fragment (1:1000 in
PBS; Cappel, West Chester, PA) for 30 min. Washed cells were viewed
with a Zeiss fluorescence microscope.
Chemical Transfection—Plasmid-DNA complexes were transiently
transfected into HeLa cells using Effectene Transfection Reagent ac-
cording to the manufacturer’s instructions (Qiagen, Valencia, CA). This
method is based on a non-liposomal lipid formulation and resulted in
low cytotoxicity and high transfection efficiency (97%) as determined
by FACS analysis. Cells were transfected for 4–6 h with tNASP-GFP,
NASP-NLS-GFP, or GFP only. Transfection was confirmed by West-
ern blotting. Lysates from HeLa cells transfected with tNASP-GFP or
NASP-NLS-GFP were separated by SDS-PAGE, Western-blotted (1),
and stained with rabbit anti-NASP antibodies and affinity-purified
goat anti-green fluorescent protein polyclonal antibodies (Rockland,
Gilbertsville, PA).
Fluorescent-activated Cell Sorting (FACS) Analysis—Control cells
and transfected cells 2, 4, 6, 8, and 24 h after release from the double
thymidine block were washed with PBS, trypsinized, and fixed with
70% ethanol for 2 h on ice. Cells were washed in PBS, stained (30 min
at 37 °C) with 50 g/ml propidium iodide in PBS (containing 200 g/ml
RNase A and 0.1% Triton X-100), and incubated overnight at 4 °C
before analysis at the University of North Carolina, Chapel Hill, Flow
Cytometry Facility. For each sample at least 10,000 cells were counted.
After gating out doublets and debris, cell cycle distribution was
analyzed using Summit version 3.1 software (Cytomation, Inc., Fort
Collins, CO). For each time point, at least three different samples were
examined.
Immunoaffinity Chromatography—Affinity chromatography was
carried out with rabbit anti-NASP (C-terminal) antibodies (30 mg)
coupled to Reacti-Gel 6 beads (Pierce; coupling efficiency 80%).
HeLa cells were trypsinized, washed twice with PBS, and solubilized by
incubation in lysis buffer: 0.01 M sodium phosphate buffer, pH 7.2, 0.15
M NaCl, containing 1% Triton X-100, 0.5% sodium deoxycholate, and
protease inhibitor mixture (Sigma) for 30 min on ice. Following centrif-
ugation (10 min, 6000  g), the pellet was sonicated, added to the
supernatant, and centrifuged again (10 min, 6000  g). The superna-
tant was collected and incubated with antibody-coupled beads over-
night at 4 °C. After washing with PBS, the bound proteins were eluted
from the beads with ImmunoPure Elution Buffer (Pierce). The eluate
pH was neutralized, and the sample was concentrated by vacuum
centrifugation. Samples were separated by SDS-PAGE on 10–20%
Tris-Cl Criterion gradient minigels (Bio-Rad) under reducing condi-
tions, blotted to Immobilon-P (Millipore Inc., Bedford, MA), and probed
for NASP and H1 histones. A C-18 reverse phase HPLC column (Wa-
ters, DeltaPak, 15 M, 300 Å, 3.9  300 mm) equilibrated with aceto-
nitrile (ACN) and 0.1% trifluoroacetic acid was used for the identifica-
tion of histone H1 subtypes as described previously (1). Briefly, proteins
were eluted at 28 °C with a multistep ACN in 0.1% trifluoroacetic acid
gradient (0.7 ml/min). Gradients were developed from 18.5 to 100%
buffer B (90% ACN in 0.1% trifluoroacetic acid) and 81.5 to 0% buffer A
(10% ACN in 0.1% trifluoroacetic acid).
DNA Supercoiling Assay and H1-NASP Complexes—To assess the
ability of H1-NASP complexes to transfer H1 to DNA, H1-NASP com-
plexes were prepared in vitro and analyzed by a DNA supercoiling
assay modified from the method of Kleinschmidt et al. (14). Calf thymus
H1 histones (Roche Molecular Biochemicals) were biotinylated using an
EZ-Link Sulfo-NHS-biotin kit (Pierce). Biotinylated H1 histones (1 g)
and tNASP (3 g) were incubated (30 min at 37 °C in PBS containing 1
mM ATP) and chromatographed in 1 SSC buffer, pH 7.4, on Micro
Bio-Spin 30 chromatography columns (Bio-Rad) to remove unbound H1
histones, which are retained by the column. Samples were evaluated by
SDS-PAGE (10–20% Tris-HCl Criterion gels, Bio-Rad) and Western
blotting to Immobilon-P membranes (Millipore, Bedford, MA). Biotiny-
lated H1 histones were detected using alkaline phosphatase-conjugated
avidin, and tNASP was detected using anti-NASP antibodies (N-termi-
nal) and an alkaline phosphatase-conjugated secondary antibody (Cap-
pel, West Chester, PA).
Supercoiled SV40 DNA (Invitrogen) was relaxed by incubation with
topoisomerase I (Invitrogen). H1 histones, tNASP, or H1-NASP com-
plexes from the Micro Bio-Spin 30 chromatography columns (described
above) were incubated with the relaxed SV40 DNA for 30 min at 37 °C
in TOPO buffer (50 mM Tris-HCl, 50 mM KCl, 10 mM MgCl2, 0.1 mM
EDTA, 0.5 mM dithiothreitol, 1.0 mM ATP, pH 7.5, with 30 g/ml bovine
serum albumin). The reactions were terminated by the addition of a
Sarkosyl-proteinase K (2% and 0.3 mg/ml final concentration, respec-
tively) mixture, which was incubated for 15 min at 37 °C. The DNA was
subsequently phenol-chloroform-extracted, ethanol-precipitated, and
analyzed by 1% agarose gel electrophoresis in 4 TAE and ethidium
bromide-stained for visualization.
Fluorescence Recovery after Photobleaching (FRAP)—HeLa cells
growing on coverslips (25–30% confluent) were transfected by pEG-
FPN1-NASP as described above. Cells were observed 24 h after trans-
fection. Coverslips with cells were mounted in metal chambers and
observed with a 40 objective in a Zeiss 410 confocal microscope using
the 488-nm laser line of an argon-krypton laser. In a FRAP experiment
one scan of the unbleached cell was acquired, followed by a single bleach
pulse of 5–10 s using a spot of rectangular shape and differing in size
depending upon the size of the bleached structure (usually 50 or 100%
of the nuclear area). Images were collected from the same section
initially at 5- or 10-s intervals (1 min) followed by 30-s intervals for 4
min. For imaging, the laser power was attenuated to 0.3% of the bleach
intensity. FRAP recovery curves were obtained from background-sub-
tracted images using GelExpert Software (Nucleotech Corp., San Car-
los, CA). The relative fluorescence in the nuclear area measured was
determined as defined by Phair and Misteli (16). The relative fluores-
cence is Irel  T0It/TtI0, where T0 is the total nuclear fluorescence
intensity before bleaching, and I0 is the fluorescence intensity of the
nuclear area to be bleached. Tt and It are the fluorescence intensities at
time t. Approximately 1% of the fluorescence was lost during imaging.
RESULTS
Localization of NASP—Indirect immunofluorescent staining
of unsynchronized HeLa cells as well as synchronized cells 2, 4,
6, and 8 h after being released from the double thymidine block
demonstrated that immediately after mitosis and continuing
throughout S and G2 phases NASP is localized in both the
nucleus and cytoplasm (Fig. 1A). In the nucleus NASP is un-
evenly distributed and appears to be excluded from nucleolar
regions. In the cytoplasm NASP is most abundant in dense
aggregations in the perinuclear regions but often can be seen as
rows of aggregates reaching the peripheral cytoplasm (Fig. 1A).
Transfection of cells with tNASP-GFP resulted in strong
nuclear staining (Fig. 1B) 2 h after transfection (97% of the
cells were transfected after 24 h). Cytoplasmic staining re-
mained weaker than the nuclear staining throughout the 24 h
of observation. Transfection of cells with NASP-NLS-GFP
resulted in strong cytoplasmic staining, particularly in the
perinuclear region, with no detectable stain in the nucleus (Fig.
1C). Control transfection with GFP only resulted in staining in
both the nucleus and cytoplasm (Fig. 1D). Immunoprecipita-
tion and Western blotting of transfected cells with anti-NASP
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and anti-GFP antiserum confirmed the expression of the con-
structs in these cells (Fig. 2A). Western blots of nuclear and
cytoplasmic fractions from non-transfected HeLa cells con-
firmed the presence of both s and t forms of NASP in the
nucleus and cytoplasm (Fig. 2B).
Association of H1 Histones with NASP—In myeloma 66-2
cells H1 histones were found to co-purify bound to native NASP
(1). Similarly in HeLa cells, isolation of NASP by HPLC size
chromatography or affinity chromatography with anti-NASP
antibodies resulted in the co-purification of H1 histones (Fig. 2,
C and D). Histone analysis by reverse phase HPLC of H1
histones extracted from H1-NASP complexes identified sub-
type H1d/e (H1.2) as the H1 histone (data not shown). Histone
H1.2 is the most abundant subtype in HeLa cells (15); however,
other histone H1 subtypes may not have been detected because
of limited amounts of sample.
Effect of the Overexpression of NASP and NASP-NLS on the
Cell Cycle—In experiments overexpressing NASP and NASP
deletion mutants in synchronized HeLa cells, we used con-
structs without the GFP sequence. Chemical transfection of
cells with the vectors expressing NASP and NASP deletion
mutants was done 24 h before the cells were released from the
double thymidine block to ensure complete expression of the
construct. Fig. 3 shows a typical experiment in which cell cycle
progression is analyzed by FACS analysis up to 8 h after
release from the double thymidine block. Overexpression of
tNASP clearly affects the progression of cells through the cell
cycle; compare Fig. 3, A and B. Similarly overexpression of
NASP-NLS affects the progression of cells through the cell
cycle; compare Fig. 3, A and C. Fig. 3, D and E, shows that cells
transfected with NASP-HBS, the mutant lacking histone-
binding sites, or sNASP do not delay progression through the
cell cycle.
Table I presents the data collected from 6 independent ex-
periments at 4 and 6 h after release from the double thymidine
block. At 4 and 6 h after release there were significantly fewer
HeLa cells, which were overexpressing tNASP, in the G2 and S
phases than there were non-overexpressing HeLa cells (71.45
versus 50.8%; p  0.01 at 4 h, and 79.85 versus 60%; p  0.01
at 6 h; Fig. 4 and Table I). Similarly there were significantly
fewer overexpressing tNASP-NLS HeLa cells than non-over-
expressing cells in the G2 and S phases (71.45 versus 53.17%;
p  0.01 at 4 h, and 79.85 versus 59.27%; p  0.01 at 6 h; Fig.
4 and Table I). There was, however, no significant difference
between tNASP and NASP-NLS (Fig. 4). Data from 2, 8, and
24 h showed no significant differences between any of the cells
tested. There was no difference in the progression of cells
through the cell cycle between untreated cells and cells treated
with delivery reagents only (Table I). At 4 and 6 h, cells trans-
fected with NASP-HBS (p  0.37 (4 h) and p  0.48 (6 h)) or
sNASP (p  0.34 (4 h) and p  0.34 (6 h)) did not significantly
delay progression through the cell cycle (Fig. 3, D and E; Table
I). These data indicate that the overexpression of tNASP is
different from the overexpression of sNASP in its effect on cell
cycle progression and that the histone-binding sites are neces-
sary for the delay in cell cycle progression. However, the pres-
ence of a NLS is not required for this effect.
DNA Supercoiling by H1-NASP Complexes—To test the abil-
ity of NASP to transfer H1 histones to DNA, calf thymus H1
histones were biotinylated and bound to tNASP in vitro, and
the H1-NASP complexes were subsequently separated by chro-
FIG. 1. Localization of NASP in HeLa cells. A, immunofluorescent
localization of NASP in HeLa cells probed with rabbit anti-recombinant
NASP. NASP appears in both the nucleus and cytoplasm. B, fluorescent
localization of NASP in HeLa cells transfected with tNASP-GFP. C,
fluorescent localization of NASP in HeLa cells transfected with the
nuclear localization signal deletion mutant (NASP-NLS-GFP). D, con-
trol. Fluorescent localization of GFP in HeLa cells transfected with GFP
only. Original digital images were taken with a 40 objective.
FIG. 2. Western blot analysis of NASP in HeLa cells. A, overex-
pression of tNASP-GFP (lanes 1 and 3) and NASP-NLS-GFP (lanes 2
and 4) in HeLa cells. Lanes 1 and 2 probed with rabbit anti-recombinant
NASP. Lanes 3 and 4 probed with anti-GFP. B, lanes 1 and 2, HeLa cell
nuclear and cytoplasmic fractions probed with rabbit anti-recombinant
NASP antibody. Lanes 3 and 4, HeLa cell nuclear and cytoplasmic
fractions probed with rabbit preimmune serum. Lanes 5 and 6, Amido
Black stain. Lanes were loaded with equal amounts of protein. cyt,
cytoplasmic; nucl, nuclear fraction. C, lane 1, eluate from an anti-
recombinant NASP antibody affinity column loaded with a HeLa cell
lysate, probed with rabbit anti-recombinant NASP antibody. Control
blots of recombinant NASP (lane 2) and affinity column eluate (lane 3)
probed with anti-NASP antibody absorbed with recombinant NASP. D,
lane 1, commercial H1 histones. Lane 2, eluate from an anti-recombi-
nant NASP antibody affinity column loaded with a HeLa cell lysate,
probed with rabbit anti-H1 histone antibody. Control blots of commer-
cial H1 histones (lane 3) and affinity column eluate (lane 4) stained with
goat anti-rabbit immunoglobulin (secondary antibody only).
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matography on Bio-Rad Micro Bio-Spin 30 (MBS30) columns.
MBS30 columns separate H1-NASP complexes from unbound
histones. Fig. 5 demonstrates that biotinylated H1 histones are
retained on the MBS30 column (lanes 1 and 2); however, when
H1 is complexed with NASP, both are eluted from the column
(lanes 4 and 6). When NASP-HBS is substituted for tNASP, it
elutes from the column (lane 5) but does not bind H1 histones
and does not non-specifically carry H1 histones through the
column (lane 3).
The separated H1-NASP complexes were incubated with re-
laxed SV40 DNA to test the ability of H1 histones to supercoil
the SV40 DNA (Fig. 6). Supercoiled and relaxed SV40 DNA are
shown in Fig. 6, lanes 1 and 2. The addition of H1 histones to
relaxed SV40 DNA causes supercoiling (lane 3), whereas the
addition of tNASP does not (lane 4). As shown in Fig. 6, lanes
6 and 7, the addition of H1-NASP complexes, which have
passed through the MBS30 column, to relaxed SV40 DNA
results in supercoiling the DNA. If H1 only is chromatographed
and the resulting eluate incubated with relaxed SV40 DNA, no
supercoiling occurs because the H1 histones are retained by the
column (lane 5). If increasing amounts of tNASP are added at
the time of the addition of H1-NASP complexes to relaxed SV40
DNA, then there is a reduction in the intensity of the super-
coiled DNA bands (Fig. 7). This indicates that tNASP competes
with DNA for H1 binding.
Mobility of NASP in the Nucleus—Given our results that
NASP and H1 histones co-purify from HeLa cells and that
NASP can transfer H1 histones to DNA in vitro, it is possible
that H1 histones not bound to DNA are bound to NASP. If
NASP-H1 complexes were present in the nucleus, then we
would expect that the mobility properties of NASP would be
similar to those of H1. Consequently, we used FRAP to deter-
mine the time necessary for NASP to move into a bleached area
of the nucleus. Bleaching 50% of a nucleus containing tNASP-
GFP (see also Fig. 1B) resulted in a recovery of fluorescence to
a plateau level of 92.5  4.6% in 220–225 s (n  3 experi-
FIG. 3. Cell cycle changes from overexpression of NASP in HeLa cells. FACS analysis demonstrating double thymidine-blocked HeLa cells
allowed to progress in synchrony through the cell cycle. A, normal progression through the cell cycle. B, overexpression of tNASP affects progression
through the cell cycle. C, overexpression of NASP-NLS (lacking nuclear localization signal) affects progression through the cell cycle. D,
overexpression of NASP-HBS (lacking histone binding sites) does not delay progression through the cell cycle. E, overexpression of sNASP
(somatic NASP) does not delay progression through the cell cycle.
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ments). Fig. 8 shows a typical experiment in which 50% of the
nucleus was bleached (Fig. 8A), and the fluorescence recovery
was 96.5  1.2% in 225 s (Fig. 8B). This compares favorably to
the 200–250 s necessary for recovery of H1-GFP fluorescence in
the nucleus (4). As fluorescence intensity increases in the
bleached area, there is a concomitant decrease in intensity in
the unbleached area (Fig. 8A), indicating that NASP is redis-
tributed within the nucleus. Because HeLa cells transfected
with tNASP-GFP have very little tNASP-GFP in the cytoplasm
(Fig. 1B), photobleaching the entire nucleus resulted in no
recovery of fluorescence in 300 s (n  3 experiments), indicat-
ing that essentially no tNASP-GFP entered the nucleus from
the cytoplasm in these experiments.
DISCUSSION
In this study we have demonstrated that the H1 histone-
binding protein NASP is present in the nucleus and cytoplasm
of HeLa cells and can be directed to the nucleus by its NLS
FIG. 4. Comparison of cells in S  G2 at 4 and 6 h after over-
expression of tNASP or tNASP-NLS in HeLa cells. Error bars
represent  S.D. Cells overexpressing either tNASP or tNASP-NLS
are significantly different from the non-overexpressing HeLa cells but
not from each other, see Table I.
FIG. 5. Western blot showing binding of H1 histones to
tNASP but not NASP-HBS. Lanes 1–4, biotinylated H1 histones
stained with alkaline phosphatase (AP)-conjugated avidin. Lanes 5
and 6, NASP stained with rabbit anti-recombinant NASP and an
alkaline phosphatase-conjugated secondary antibody. Lane 1, control.
Biotinylated H1 (1 g) not chromatographed on a Micro Bio-Spin 30
column. Lane 2, negative. Biotinylated H1 (1 g) chromatographed on
and retained by a Micro Bio-Spin 30 column. Lane 3, negative. Bioti-
nylated H1 (1 g) 	 NASP-HBS (3 g) chromatographed on a Micro
Bio-Spin 30 column with the biotinylated H1 retained. Lane 4, bioti-
nylated H1 (1 g) 	 tNASP (3 g) chromatographed on a Micro
Bio-Spin 30 column with the biotinylated H1 carried by the tNASP.
Lane 5, biotinylated H1 (1 g) 	 NASP-HBS (3 g) chromato-
graphed on a Micro Bio-Spin 30 column with biotinylated H1 not
bound by the NASP-HBS, anti-NASP probed. Lane 6, biotinylated
H1 (1 g) 	 tNASP (3 g) chromatographed on a Micro Bio-Spin 30
column with the biotinylated H1 carried by the tNASP, anti-NASP
probed.
TABLE I
Percent of cells in S	G2 phase
The abbreviations used are as follows: N, normal HeLa cells; tN, full-length tNASP sequence; NLS-, NASP-NLS; HBS-, NASP-HBS; sN,
full-length sNASP; t test  Student’s t test; NS, not significant.









Exp. 1 60.70 42.90 49.30
Exp. 2 62.90 52.20 52.80
Exp. 3 71.30 57.30 57.40
Exp. 4 86.70 88.10 73.60
Exp. 5 70.10 53.10 46.40
Exp. 6 77.00 86.90 79.40 79.30
Mean 71.45 50.80 53.17 76.03 66.47
S.D. 9.53 7.30 4.06 19.87 17.62
t test, N vs. tN 0.01 p  0.01
t test, N vs. NLS- 0.003 p  0.01
t test, N vs. HBS- 0.37 NS
t test, N vs. sN 0.34 NS









Exp. 1 72.90 51.20 50.10
Exp. 2 71.60 61.50 63.70
Exp. 3 78.80 67.30 64.00
Exp. 4 88.50 88.60 81.00
Exp. 5 78.50 61.30 56.40
Exp. 6 88.80 87.90 88.00 88.80
Mean 79.85 60.00 59.27 79.27 75.13
S.D. 7.41 8.15 7.94 15.56 16.60
t test, N vs. tN 0.01 p  0.01
t test, N vs. NLS- 0.01 p  0.01
t test, N vs. HBS- 0.48 NS
t test, N vs. sN 0.34 NS
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(Fig. 1). Even though transfection of cells with tNASP-GFP
resulted in almost complete nuclear localization of the con-
struct, endogenous NASP is clearly not exclusively in the nu-
cleus (Figs. 1 and 2). From Western blotting (Fig. 2) it would
appear that there is less tNASP in the nucleus than in the
cytoplasm, whereas sNASP is more evenly distributed between
the two compartments. Because tNASP occurs in rapidly divid-
ing cell populations (gametes, embryonic cells, and trans-
formed cells), its presence in the cytoplasm may serve as a
storage site for excess linker (H1) histones. Alternatively, the
majority of NASP in the cytoplasm could simply reflect a lag-
ging degradation mechanism in rapidly dividing cells because
in normal somatic cells there is little or no NASP in the cyto-
plasm (1).
Overexpression of tNASP significantly delays the progres-
sion of cells through the cell cycle, and surprisingly, overex-
pression of NASP-NLS also significantly delays progression
through the cell cycle (Fig. 3 and Table I). However, overex-
pression of sNASP does not appear to have a significant effect.
The most obvious difference between tNASP (Mr 83,934) and
sNASP (Mr 45,751) is the presence of an additional histone-
binding site (1, 11). The identical C-terminal sequences of
tNASP and sNASP contain a leucine zipper flanked by coiled
coil regions downstream and possible DNA-binding sites up-
stream; these structural features are often indicative of protein
dimers that bind DNA (17). If tNASP dimers form in the
cytoplasm and bind H1 histones, then the overexpression of
tNASP may result in insufficient linker histones for DNA rep-
FIG. 6. Transfer of H1 histones to DNA from tNASP using a
DNA-supercoiling assay. Lane 1, supercoiled SV40 DNA. Lane 2,
relaxed SV40 DNA, supercoiled SV40 DNA relaxed with topoisomerase
I. Lane 3, relaxed SV40 DNA with increased supercoiling due to addi-
tion of H1 (1 g). Lane 4, relaxed SV40 DNA with no supercoiling
induced by added tNASP (1 g). Lanes 5–7, samples chromatographed
on a Micro Bio-Spin 30 column (see Fig. 5). Lane 5, H1 (1 g), control H1
was retained by the column and consequently no supercoiling was
detected. Lane 6, H1 (1 g) 	 tNASP (2 g). Lane 7, H1 (2 g) 	 tNASP
(2 g). In the presence of tNASP, the H1-tNASP complex forms, passes
through the column, and subsequently increases DNA supercoiling.
Lane 8, supercoiled DNA standard sizes: 16,210, 14,174, 12,138, 10,102,
8,066, 7,045, 6,030, 5,012, 3,990, 2,972, and 2,067 bp.
FIG. 7. Competition of DNA and tNASP for H1. Lane 1, relaxed
SV40 DNA, supercoiled SV40 DNA relaxed with topoisomerase I. Lane
2, H1 (1 g) 	 tNASP (2 g), supercoiling of relaxed SV40 DNA due to
transfer of H1 from NASP. Lane 3, H1 (1 g) 	 tNASP (2 g) 	
additional tNASP (2 g); in the presence of additional (2 g) tNASP,
competition between tNASP and DNA for H1-reduced DNA supercoil-
ing. Lane 4, H1 (1 g) 	 tNASP (2 g) 	 additional tNASP (4 g); in the
presence of additional (4 g) tNASP, competition between tNASP and
DNA for H1 reduced DNA supercoiling further. Lane 5, control super-
coiled SV40 DNA. Lane 6, blank. Lane 7, supercoiled DNA standard
sizes: 16,210, 14,174, 12,138, 10,102, 8,066, 7,045, 6,030, 5,012, 3,990,
2,972, and 2,067 bp.
FIG. 8. FRAP of tNASP in HeLa cell nucleus. A, bleach and
recovery of fluorescent GFP-tNASP in a HeLa cell nucleus. The HeLa
cell was transfected with GFP-tNASP. The rectangle in the bleach panel
indicates the size of the bleached area. B, relative recovery of fluores-
cence intensity in the nucleus shown in A; 96.5% recovery in 225 s.
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lication. The only other notable difference between tNASP and
sNASP is the presence of two additional ATP/GTP-binding
sites in tNASP. These sites may be important for the functional
attributes of tNASP and its role in chromatin remodeling.
Additionally, this study has demonstrated in vitro that H1-
NASP complexes can cause the supercoiling of relaxed SV40
DNA by transferring H1 from NASP to DNA and importantly
that excess tNASP can compete with DNA for H1. Klein-
schmidt et al. (14) first demonstrated the transfer of histone to
DNA from the Xenopus laevis form of NASP (N1/N2). Conse-
quently, our results are consistent with the hypothesis that an
equilibrium exists between NASP-H1 histone complexes and
H1 histones bound to DNA. This equilibrium influences the
availability of H1 histones to DNA and affects the progression
of the cell through the G1/S phase transition. It can be upset by
overexpression of tNASP with its extra histone-binding site
and is consistent with the observation that H1 histone overex-
pression has been shown to slow G1/S phase progression (5) and
in some cases inhibit transcription initiation (6).
Recent reports of the mobility of H1 histones in the nucleus
(3, 4) concluded that an intermediate (4) or modulating protein
(3) might be present to regulate the movement of H1. By using
FRAP experiments on HeLa cells, this study has demonstrated
that the mobility of NASP in the nucleus is essentially the
same as that of H1 histones (Fig. 8). Although it could be
fortuitous that the recovery times are similar, one interpreta-
tion of this result is that NASP and H1 have identical mobility
characteristics because they are in a complex together in the
nucleus. This interpretation is supported by the results from
the co-precipitation experiments (Fig. 2). The recovery times of
NASP and H1 (225 s) differ markedly from other nuclear
proteins. For example, GFP-HMG-17 and GFP-SF2/ASF have
recovery times on the order of 30 s, whereas histone H2B has
no recovery over 90 s (16). The less mobile (immobile) fraction
determined in a FRAP experiment is a reflection of the resi-
dence time of the molecule in a compartment or complex and
can be modified by various treatments such as acetylation (4).
Small immobile fractions (10%, e.g. GFP-SF2/ASF (16)) indi-
cate that most of the molecules are replaced within the meas-
ured time, while large immobile fractions indicate that very
few of the molecules are replaced. Histone H2B would appear
to be replaced in the nucleosome very infrequently (16),
whereas H1 histones are replaced every 200–250 s (4). The
immobile fractions of NASP and H1 vary (3.5% NASP versus
9–26% for H1), but their recovery times (225 s) are similar,
which may indicate populations of H1 and NASP that are not
complexed with each other or are in different phosphorylation
or acetylation states. Phosphorylation of linker histones is
known to inhibit chromatin remodeling (2, 18), and NASP may
serve to mediate such interactions. Taken together, the results
presented in this study indicate that NASP is most likely the
H1-regulating protein in the nucleus and that a dynamic equi-
librium exists between NASP-H1 complexes and DNA.
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